Plant regulatory elements derived from medicago truncatula 3′UTR sequences, and uses thereof

US10501749B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10501749-B2
Application numberUS-201815882964-A
CountryUS
Kind codeB2
Filing dateJan 29, 2018
Priority dateMar 14, 2013
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Recombinant DNA molecules and constructs useful for modulating gene expression in plants, including molecules derived from Medicago truncatula sequences, are provided. plants, plant cells, plant parts, and seeds comprising recombinant DNA molecules operably linked to heterologous transcribable DNA molecules are further provided, as are methods of their use.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: a) a DNA sequence comprising SEQ ID NO:3; and b) a fragment comprising at least 200 contiguous nucleotides of SEQ ID NO:3, wherein the fragment has gene-regulatory activity; wherein said DNA sequence is operably linked to a heterologous transcribable DNA molecule. 2. The recombinant DNA molecule of claim 1 , wherein said DNA sequence comprises SEQ ID NO:3. 3. The recombinant DNA molecule of claim 1 , wherein the heterologous transcribable polynucleotide molecule comprises a gene of agronomic interest. 4. The recombinant DNA molecule of claim 3 , wherein the gene of agronomic interest confers herbicide tolerance in plants. 5. The recombinant DNA molecule of claim 3 , wherein the gene of agronomic interest confers pest resistance in plants. 6. A transgenic plant cell comprising a recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: a) a DNA sequence comprising SEQ ID NO:3; and b) a fragment comprising at least 200 contiguous nucleotides of SEQ ID NO:3, wherein the fragment has gene-regulatory activity; wherein said DNA sequence is operably linked to a heterologous transcribable DNA molecule. 7. The transgenic plant cell of claim 6 , wherein said transgenic plant cell is a monocotyledonous plant cell. 8. The transgenic plant cell of claim 6 , wherein said transgenic plant cell is a dicotyledonous plant cell. 9. A transgenic plant, or part thereof, comprising a recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: a) a DNA sequence comprising SEQ ID NO:3; and b) a fragment comprising at least 200 contiguous nucleotides of SEQ ID NO:3, wherein the fragment has gene-regulatory activity; wherein said DNA sequence is operably linked to a heterologous transcribable DNA molecule. 10. A progeny plant of the transgenic plant of claim 9 , or a part thereof, wherein the progeny plant or part thereof comprises said recombinant DNA molecule. 11. A transgenic seed of the transgenic plant of claim 9 wherein the transgenic seed comprises the recombinant DNA molecule. 12. A method of producing a commodity product comprising obtaining a transgenic plant or part thereof according to claim 9 and producing the commodity product therefrom. 13. The method of claim 12 , wherein the commodity product is protein concentrate, protein isolate, grain, starch, seeds, meal, flour, biomass, or seed oil. 14. A method of producing a transgenic plant comprising: a) transforming a plant cell with the recombinant DNA molecule of claim 1 to produce a transformed plant cell; and b) regenerating a transgenic plant from the transformed plant cell.

Assignees

Inventors

Classifications

  • Phenotypically and genetically modified plants via recombinant DNA technology · CPC title

  • for biotic stress resistance, pathogen resistance, disease resistance · CPC title

  • Methods for controlling, regulating or enhancing expression of transgenes in plant cells · CPC title

  • for herbicide resistance · CPC title

  • with agronomic (input) traits, e.g. crop yield · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10501749B2 cover?
Recombinant DNA molecules and constructs useful for modulating gene expression in plants, including molecules derived from Medicago truncatula sequences, are provided. plants, plant cells, plant parts, and seeds comprising recombinant DNA molecules operably linked to heterologous transcribable DNA molecules are further provided, as are methods of their use.
Who is the assignee on this patent?
Monsanto Technology Llc
What technology area does this patent fall under?
Primary CPC classification C12N15/8279. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).